Free fatty acids reduce splanchnic and peripheral glucose uptake in patients with type 2 diabetes

Diabetes

Volumn 51, Issue 10, 2002, Pages 3043-3048

  Bajaj, Mandeep ^a   Pratipanawatr, Thongchai ^a   Berria, Rachele ^a   Pratipanawatr, Wilailak ^a   Kashyap, Sangeeta ^a   Cusi, Kenneth ^a   Mandarine, Lawrence ^a   DeFronzo, Ralph A ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; HEPARIN; INSULIN; INTRALIPID; SODIUM CHLORIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW;

EID: 0036789244     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.3043     Document Type: Article

References (45)

1. Katz LD, Glickman MG, Rapoport S, Ferrannini E, DeFronzo RA: Splanchnic and peripheral disposal of oral glucose in man. Diabetes 32:675-679, 1983
2. DeFronzo RA, Ferrannini E, Hendler R, Felig P, Wahren J: Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 32:35-45, 1983
3. DeFronzo RA, Ferrannini E, Hendler R, Wahren J, Felig P: Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange. Proc Natl Acad Sci U S A 75:5173-5177, 1978
4. Ferrannini E, Simonson DC, Katz LD, Reichard G, Bevilacqua S, Barrett EJ, Olsson M, DeFronzo RA: The disposal of an oral glucose load in patients with non-insulin dependent diabetes. Metabolism 37:79-85, 1988
5. Adkins BA, Myers SR, Hendrick GK, Williams PE, Stevenson RW, Cherrington AD: Importance of the route of intravenous glucose delivery on hepatic glucose balance in the conscious dog. J Clin Invest 79:557-565, 1987
6. Moore MC, Hseih PS, Neal DW, Cherrington AD: Nonhepatic response to portal glucose delivery in conscious dogs. Am J Physiol 279:E1271-E1277, 2000
7. DeFronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J: Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent diabetes mellitus. J Clin Invest 76:149-155, 1985
8. DeFronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5:177-269, 1997
9. Groop LC, Bonadonna RC, Del Prato S, Ratheiser K, Zyck K, DeFronzo RA: Glucose and free fatty acid metabolism in non-insulin-dependant diabetes mellitus: evidence for multiple sites of insulin resistance. J Clin Invest 84:205-213, 1989
10. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 72:96-107, 1991
11. Reaven GM: The fourth Musketeer: from Alexandre Dumas to Claude Bernard. Diabetotogia 38:3-13, 1995
12. Thiebaud D, DeFronzo RA, Jacot E, Golay A, Acheson K, Maeder E, Jequier E, Felber JP: Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism 31:1128-1136, 1982
13. Felber JP, Ferrannini E, Golay A, Meyer HV, Thiebaud D, Curchod B, Maeder E, Jequier E, DeFronzo RA: Role of lipid oxidation in the pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36:1341-1350, 1987
14. Boden G, Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 96: 1261-1268, 1995
15. Boden G: Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10, 1997
16. Roden M, Krssak M, Stingl H, Gruber S, Hofer A, Furnsinn C, Moser E, Waldhausl W: Rapid impairment of skeletal muscle glucose transport/ phosphorylation by free fatty acids in humans. Diabetes 48:358-364, 1999
17. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI: Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865, 1996
18. Randle PJ, Newsholme EA, Garland PB: Regulation of glucose uptake by muscle: effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 93:652-665, 1964
19. Chen X, Iqbal N, Boden G: The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103:365-372, 1999
20. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA: Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747, 1983
21. Tippett PS, Neel KE: Specific inhibition of glucokinase by long chain acyl coenzymes A below the critical micelle concentration. J Biol Chem 257:12839-12845, 1982
22. Caro JF, Triester S, Patel VK, Tapscott EB, Frazier NL, Dohm GL: Liver glucokinase: decreased activity in patients with type II diabetes. Horm Metab Res 27:19-22, 1995
23. Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, Olefsky JM: Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J Clin Invest 100:2354-2361, 1997
24. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, Gerich J: Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39:1381-1390, 1990
25. Basu A, Basu R, Shah P, Vella A, Johnson CM, Nair KS, Jensen MD, Schwenk WF, Rizza RA: Effects of type 2 diabetes on the ability of insulin and glucose to regulate splanchnic and muscle glucose metabolism: evidence for a defect in hepatic glucokinase activity. Diabetes 49:272-283, 2000
26. McMahon M, Marsh HM, Rizza RA: Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM. Diabetes 38:291-303, 1989
27. Ferrannini E, Wahren J, Felig P, DeFronzo RA: Role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. Metabolism 29:28-35, 1980
28. Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, Olefsky JM: A noninvasive method to measure splanchnic glucose uptake after oral glucose administration. J Clin Invest 95:2232-2238, 1995
29. DeFronzo RA, Tobin J, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
30. Steele R: Influence of glucose loading and of injected insulin on hepatic glucose output. Ann N YAcad Sci 82:420-430, 1959
31. Kuyumjian J, Kalant N: Absorption of an oral glucose load in the dog. Horm Metab Res 18:587-589, 1986
32. Burguera B, Dudek RW, Caro JF: Liver GLUT-2 protein is not upregulated in non-insulin dependant diabetes. Horm Metab Res 27:341-343, 1995
33. Burcelin R, Eddouks M, Kande J, Assan R, Girard J: Evidence that GLUT-2 mRNA and protein concentrations are decreased by hyperinsulinemia and increased by hyperglycemia in liver of diabetic rats. Biochem J 288:675-679, 1992
34. Velho G, Petersen KF, Perseghin G, Hwang JH, Rothman DL, Pueyo ME, Cline GW, Froguel P, Shulman GI: Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 98:1755-1761, 1996
35. Giaccari A, Rossetti L: Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats. J Clin Invest 89:36-45, 1992
36. Bali D, Svetlanov A, Lee HW, Fusco-DeMane D, Leiser M, Li B, Barzilai N, Surana M, Hou H, Fleischer N, DePinho R, Rossetti L, Efrat S: Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem 270:21464 -21467, 1995
37. Rigalleau V, Binnert C, Minehira K, Stefanoni N, Schneiter P, Henchoz E, Matzinger O, Cayeux C, Jequier E, Tappy L: In normal men, free fatty acids reduce peripheral but not splanchnic glucose uptake. Diabetes 50:727-732, 2001
38. Nawano M, Oku A, Ueta K, Umebayashi I, Ishirahara T, Arakawa K, Saito A, Anai M, Kikuchi M, Asano T: Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. Am J Physiol 278:E535-E543, 2000
39. Myers SR, McGuinness OP, Neal DW, Cherrington AD: Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration. J Clin Invest 87:930-939, 1991
40. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789, 1963
41. Bonadonna RC, Zych K, Boni C, Ferrannini E, DeFronzo RA: Time dependence of the interaction between lipid and glucose metabolism in humans. Am J Physiol 257:E49-E56, 1989
42. Pendergrass M, Nucci G, DeFronzo R: In vivo glucose transport and phosphorylation in skeletal muscle are impaired by elevation of plasma FFA (Abstract). Diabetes 47 (Suppl. 1.):65A, 1998
43. Boden G, Jadali F, White J, Liang Y, Mozzoli M, Chen X, Coleman E, Smith C: Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88:960-966, 1991
44. Shah P, Vella A, Basu A, Basu R, Adkins A, Schwenk WF, Johnson CM, Nair KS, Jensen MD, Rizza RA: Effects of free fatty acids and glycerol on splanchnic glucose metabolism and insulin extraction in nondiabetic humans. Diabetes 51:301-310, 2002
45. Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, Strassmann PG, Wajchenberg BL: Overnight lowering of free fatty acids with acipimox improves insulin resistance in obese diabetic and non-diabetic subjects. Diabetes 48:1836-1841, 1999